KPMA asked compensational measures for losses caused by implementation of separation system.

Published: 2000-03-30 10:59:00

Updated: 2000-03-30 10:59:00

The KMA claimed their position of the current industrial business difficulties and asked for in one way or the other an appropriate compensational measure to be made for about 250 billion won of financial burdens accrued from the additional costs of package changes, of the drug efficacy equivalen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK